glp-1 87 kg journey Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The expanding landscape of GLP-1

And Zepbound (tirzepatide) is one of the latest additions in the GLP-1 landscape, one specifically approved by the Food and Drug Administration (FDA) for chronic weight management

Exp Mol Med

May 18, 2022.

[DOI] [PMC free article] [PubMed] [Google Scholar] [43].Tran KT, Gavitt TD, Farrell NJ, Curry EJ, Mara AB, Patel A, Brown L, Kilpatrick S, Piotrowska R, Mishra N, Transdermal microneedles for the programmable burst release of multiple vaccine payloads, Nature Biomedical Engineering 5(9) (2021) 9981007

These results far exceed the Phase 2 trial outcomes and position retatrutide as potentially the most effective weight loss medication in development